Search research articles
Contact Us
Filters
Showing results (571-580 of 601) with videos related to
Page
of 61
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2017
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202
N Lynn Henry, Joseph M Unger, Anne F Schott, et al.
Cancer Medicine
|
August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial
Laurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
Journal of the National Cancer Institute
|
May 15, 2023
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer
Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi, et al.
Frontiers in Rehabilitation Sciences
|
February 24, 2023
Widespread clinical implementation of the teen online problem-solving program: Progress, barriers, and lessons learned
Shari L Wade, Kathleen Walsh, Beth S Slomine, et al.
Cancer Chemotherapy and Pharmacology
|
April 11, 2014
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
Pierre Maison-Blanche, Shaker Dakhil, Ari Baron, et al.
Journal of the Endocrine Society
|
May 8, 2023
A Pilot Randomized Clinical Trial of Intranasal Oxytocin to Promote Weight Loss in Individuals With Hypothalamic Obesity
Shana E McCormack, Zi Wang, Kristin L Wade, et al.
Cancer Chemotherapy and Pharmacology
|
August 9, 2025
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated
Tanner J Freeman, Thomas J George, Samuel A Jacobs, et al.
Journal of Neurotrauma
|
June 8, 2011
Recommendations for the use of common outcome measures in pediatric traumatic brain injury research
Stephen R McCauley, Elisabeth A Wilde, Vicki A Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2021
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
Katherine S Virgo, R Bryan Rumble, Ronald de Wit, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2021
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)
Natasha B Leighl, Mary W Redman, Naiyer Rizvi, et al.
Page
of 61
Search research articles
Search
Showing results (571-580 of 601) with videos related to
Sort By:
Page
of 61
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 15, 2017
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202
N Lynn Henry, Joseph M Unger, Anne F Schott, et al.
Cancer Medicine
|
August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial
Laurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
Journal of the National Cancer Institute
|
May 15, 2023
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer
Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi, et al.
Frontiers in Rehabilitation Sciences
|
February 24, 2023
Widespread clinical implementation of the teen online problem-solving program: Progress, barriers, and lessons learned
Shari L Wade, Kathleen Walsh, Beth S Slomine, et al.
Cancer Chemotherapy and Pharmacology
|
April 11, 2014
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
Pierre Maison-Blanche, Shaker Dakhil, Ari Baron, et al.
Journal of the Endocrine Society
|
May 8, 2023
A Pilot Randomized Clinical Trial of Intranasal Oxytocin to Promote Weight Loss in Individuals With Hypothalamic Obesity
Shana E McCormack, Zi Wang, Kristin L Wade, et al.
Cancer Chemotherapy and Pharmacology
|
August 9, 2025
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated
Tanner J Freeman, Thomas J George, Samuel A Jacobs, et al.
Journal of Neurotrauma
|
June 8, 2011
Recommendations for the use of common outcome measures in pediatric traumatic brain injury research
Stephen R McCauley, Elisabeth A Wilde, Vicki A Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2021
Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
Katherine S Virgo, R Bryan Rumble, Ronald de Wit, et al.
Journal for Immunotherapy of Cancer
|
August 25, 2021
Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)
Natasha B Leighl, Mary W Redman, Naiyer Rizvi, et al.
Page
of 61